Reposting for those that missed it.. this came from our "dear friends" at STAT.. Actrema / Tocilizumab is possibly worse than Sarilumab (Kevzara ... this gave my friend a secondary infection) ... Leronlimab is far and away the safest.

All IL6 Inhibitors have this flaw.

https://www.statnews.com/2017/06/05/actemra-r...ritis-fda/

Quote:

---

Failure to warn: Hundreds died while taking an arthritis drug, but nobody alerted patients
By CHARLES PILLERJUNE 5, 2017

Treatments for the disabling disease afflicting about 1.5 million Americans can have terrifying side effects, so doctors and patients were excited when Actemra reached the U.S. market in 2010. Unlike competing drugs, it wasn’t associated with heart attacks, heart failure, or life-threatening lung complications.

Yet hundreds of patients taking Actemra have died from such problems, and many more have suffered harm. STAT analyzed more than 500,000 side-effect reports on rheumatoid arthritis drugs, and found clear evidence that the risks of heart attacks, strokes, heart failure, and other conditions were as high or higher for Actemra patients than for patients taking some competing drugs.

Most of those medications warn about these risks on their labels. Actemra does not.

---

https://investorshangout.com/post/view?id=5772972